Groundbreaking Research by Professor Deng Xuliang's team from Peking University School and Hospital of Stomatology Recognized Among "Important Medical Advances in China in 2024"
A pioneering study led by Professor Deng Xuliang and his team from Peking University School and Hospital of Stomatology, "Revealing a Novel Nanozyme Mechanism for Significantly Improving Wound Healing in Diabetic Patients", has been named one of China’s Important Medical Advances for 2024. Announced at the China Medical Development Conference by the Chinese Academy of Medical Sciences (CAMS), this achievement stands as the only selected breakthrough in stomatology this year.
Titled "Revealing a Novel Nanozyme Mechanism for Enhanced Diabetic Wound Healing," the research addresses the pathological microenvironment of craniofacial wounds in diabetic patients. By combining tellurium (Te) with traditional platinum-copper (PtCu), the team innovatively constructed a novel two-dimensional PtCuTe nanozyme. This breakthrough achieved efficient ROS scavenging, ROS-independent antibacterial activity, angiogenesis promotion, anti-inflammation, and immune regulation, significantly promoting tissue regeneration and offering a promising therapeutic strategy for diabetic craniofacial wound treatment.
· About China’s Annual Major Medical Advances
The release of "China's Annual Major Medical Advances" aims to highlight the nation’s most impactful medical innovations, fostering scientific literacy, guiding research priorities, and elevating public engagement with medical science. Since its launch in 2020, it has been released for six consecutive years. The selected advances each year represent China's most significant medical research achievements and have received extensive attention from society and the scientific community.
For the 2024 selection, the CAMS Academic Consulting Committee evaluated over 310,000 entries, including:
·Research papers by Chinese scholars (October 2023–December 2024)
·Approved innovative drugs, medical devices, and priority medical devices
Through rigorous big-data analysis and expert deliberation, 13 landmark advances were finalized across six categories:
·Clinical Medicine (3) | Stomatology (1) | Population Health (2)
·Pharmacy (2) | Medical Life Sciences (1) | Engineering & Informatics (4)
These advances are expected to significantly enhance disease prevention and treatment levels globally.